FI47366C - The process prepares new therapeutically active indole derivatives. - Google Patents
The process prepares new therapeutically active indole derivatives.Info
- Publication number
- FI47366C FI47366C FI670617A FI61767A FI47366C FI 47366 C FI47366 C FI 47366C FI 670617 A FI670617 A FI 670617A FI 61767 A FI61767 A FI 61767A FI 47366 C FI47366 C FI 47366C
- Authority
- FI
- Finland
- Prior art keywords
- therapeutically active
- indole derivatives
- process prepares
- new therapeutically
- prepares new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH898666A CH469002A (en) | 1966-06-21 | 1966-06-21 | Process for the production of new indole derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
FI47366B FI47366B (en) | 1973-07-31 |
FI47366C true FI47366C (en) | 1973-11-12 |
Family
ID=4347068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI670617A FI47366C (en) | 1966-06-21 | 1967-03-02 | The process prepares new therapeutically active indole derivatives. |
Country Status (7)
Country | Link |
---|---|
AT (1) | AT266822B (en) |
CH (1) | CH469002A (en) |
CS (1) | CS156407B2 (en) |
DK (1) | DK124612B (en) |
ES (1) | ES337458A1 (en) |
FI (1) | FI47366C (en) |
SE (1) | SE308110B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1980000152A1 (en) * | 1978-07-03 | 1980-02-07 | Sandoz Ag | 3-aminopropoxy-aryl derivates,preparation and use thereof |
EP0013878A1 (en) * | 1979-01-18 | 1980-08-06 | Sandoz Ag | 3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them |
AP2005003232A0 (en) | 2002-08-19 | 2005-03-31 | Pfizer Prod Inc | Combination therapy for hyperproliferative diseases. |
GT200600381A (en) | 2005-08-25 | 2007-03-28 | ORGANIC COMPOUNDS | |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US8404896B2 (en) | 2006-12-01 | 2013-03-26 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
WO2008112287A1 (en) | 2007-03-12 | 2008-09-18 | Nektar Therapeutics | Oligomer-beta blocker conjugates |
BR112015026513A2 (en) | 2013-04-17 | 2017-07-25 | Pfizer | n-piperidin-3-ylbenzamide derivatives to treat cardiovascular disease |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
MX2021008533A (en) | 2019-01-18 | 2021-08-19 | Astrazeneca Ab | Pcsk9 inhibitors and methods of use thereof. |
-
1966
- 1966-06-21 CH CH898666A patent/CH469002A/en unknown
-
1967
- 1967-03-02 FI FI670617A patent/FI47366C/en active
- 1967-03-02 ES ES337458A patent/ES337458A1/en not_active Expired
- 1967-03-02 CS CS155767A patent/CS156407B2/cs unknown
- 1967-03-03 AT AT206067A patent/AT266822B/en active
- 1967-03-03 DK DK112967AA patent/DK124612B/en unknown
- 1967-03-03 SE SE2931/67A patent/SE308110B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ES337458A1 (en) | 1968-03-01 |
CH469002A (en) | 1969-02-28 |
SE308110B (en) | 1969-02-03 |
CS156407B2 (en) | 1974-07-24 |
DK124612B (en) | 1972-11-06 |
FI47366B (en) | 1973-07-31 |
AT266822B (en) | 1968-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI52858C (en) | Process for the preparation of therapeutically active 1- (beta-aryl) ethylimidazole derivatives. | |
FI49497C (en) | Process for the preparation of therapeutically active 1-phenoxy-2-3-alkylaminopropanes. | |
FI50707C (en) | Process for the preparation of new pharmacologically active hydroxycyclohexylamines. | |
FI52335C (en) | Process for the preparation of therapeutically active ethylamine derivatives. | |
FI48348C (en) | Therapeutically useful pyrrylamino ketone derivatives. | |
FI47366C (en) | The process prepares new therapeutically active indole derivatives. | |
FI46373C (en) | A process for the preparation of new therapeutically useful derivatives of phenylaminopropane. | |
DK121168B (en) | Process for the preparation of indole derivatives. | |
FI48083C (en) | Process for the preparation of new therapeutically active imidazole derivatives | |
FI44801C (en) | Process for the preparation of new therapeutically active basic ethers. | |
DK117635B (en) | Analogous process for the preparation of therapeutically active 3- (piperazinoalkyl) -pyrazoles. | |
GR32294B (en) | METHOD FOR THE PRODUCTION OF ANTI-RI - GLOVOULINIS. | |
FI46160C (en) | The process prepares new therapeutically active indole derivatives. | |
FI47189C (en) | Process for the preparation of therapeutically active d-lysergic acid-N-phenylpiperazides. | |
FI48190C (en) | Process for the preparation of therapeutically active 10alpha-methoxy-9,10-dihydroergoline derivatives | |
FI44607C (en) | The process prepares therapeutically active N-acylated halogen-benzene-2,4-disulfonamides. | |
FI47661C (en) | Process for the preparation of therapeutically active benzofuran derivatives. | |
FI48732C (en) | Process for the preparation of pharmacologically active 3-substituted-α-mino-1,2,3,4-tetrahydrocarbazoles. | |
FI47488C (en) | Process for the preparation of 1-alkyl-2,3-dihydro-5-phenyl-1H-1,4-benzodiazepines. | |
FI50879C (en) | Process for the preparation of therapeutically active substituted 3-aminoacylamino-thiophenes. | |
DK126648B (en) | Contraceptive-acting progesterone derivative. | |
FI49038C (en) | Analogous process for the preparation of new pharmacologically active 4-phenyl-1H-quinazolin-2-one derivatives. | |
FI46066C (en) | Analogous process for the preparation of therapeutically active N, N-dimethylamino-ethyl-14beta-hydroxy-5beta-pregn-20-ene-21-carboxylates. | |
FI43987C (en) | Process for the preparation of pharmacologically active 10-aminoalkyl-dibenz (b, f) azepine derivatives | |
FI45553C (en) | Method for the preparation of therapeutically useful 16-thio-substituted 9beta, 10a lfa-pregnenes |